Search by Drug Name or NDC
NDC 00069-3500-02 ZAVZPRET 10 mg/.1mL Details
ZAVZPRET 10 mg/.1mL
ZAVZPRET is a NASAL SPRAY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is ZAVEGEPANT HYDROCHLORIDE.
MedlinePlus Drug Summary
Zavegepant nasal spray is used to treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light). Zavegepant is in a class of medications called calcitonin gene-related peptide receptor antagonists. It works by blocking the action of a certain natural substance in the body that causes migraine headaches. Zavegepant does not prevent migraine attacks or reduce the number of headaches you have.
Related Packages: 00069-3500-02Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Zavegepant Nasal Spray
Product Information
| NDC | 00069-3500 |
|---|---|
| Product ID | 0069-3500_13080956-f883-468c-be4f-e8b503a7fbc1 |
| Associated GPIs | |
| GCN Sequence Number | 084508 |
| GCN Sequence Number Description | zavegepant HCl SPRAY 10 MG NASAL |
| HIC3 | H3F |
| HIC3 Description | ANTIMIGRAINE PREPARATIONS |
| GCN | 53837 |
| HICL Sequence Number | 048771 |
| HICL Sequence Number Description | ZAVEGEPANT HCL |
| Brand/Generic | Brand |
| Proprietary Name | ZAVZPRET |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | zavegepant |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY |
| Route | NASAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/.1mL |
| Substance Name | ZAVEGEPANT HYDROCHLORIDE |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA216386 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00069-3500-02 (00069350002)
| NDC Package Code | 0069-3500-02 |
|---|---|
| Billing NDC | 00069350002 |
| Package | 6 BLISTER PACK in 1 CARTON (0069-3500-02) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK (0069-3500-01) / .1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2023-06-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 175.943 |
| Pricing Unit | EA |
| Effective Date | 2023-10-18 |
| NDC Description | ZAVZPRET 10 MG NASAL SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis